TNF Pharmaceuticals Inc [NASDAQ: TNFA] gained 8247934% or 4269999.86 points to close at $4270000.0 with a heavy trading volume of 8247934 shares.
It opened the trading session at $0.1339, the shares rose to $0.1435 and dropped to $0.1255, the range by which the price of stock traded the whole day. The daily chart for TNFA points out that the company has recorded -90.36% loss over the past six months.
If we look at the average trading volume of 4.27M shares, TNFA reached to a volume of 8247934 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about TNF Pharmaceuticals Inc [TNFA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNFA shares is $32.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNFA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 0.12, with the Price to Cash per share for the same quarter was set at 0.41.
Trading performance analysis for TNFA stock
TNF Pharmaceuticals Inc [TNFA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.25. With this latest performance, TNFA shares dropped by -14.18% in over the last four-week period, additionally sinking by -90.36% over the last 6 months – not to mention a drop of -87.84% in the past year of trading.
TNF Pharmaceuticals Inc [TNFA]: A deeper dive into fundamental analysis
Return on Equity for this stock declined to -88.26%, with Return on Assets sitting at -88.26%.
An analysis of Institutional ownership at TNF Pharmaceuticals Inc [TNFA]
There are presently around $3.43%, or 3.44% of TNFA stock, in the hands of institutional investors.
